Table 3.
Patients’ characteristics and compositions of recurrent CBD stones
| Bilirubinate | Cholesterol | P | |
| (n = 38) | (n = 3) | ||
| Age (yr) | 66 ± 10 | 65 ± 6 | 0.836 |
| Sex (M/F) | 21/17 | 3/0 | 0.254 |
| CBD diameter (cm) | 1.9 ± 0.6 | 1.4 ± 0.2 | 0.159 |
| Stone number (S/M) | 16/22 | 1/2 | 1.000 |
| Stone size (cm) | 1.4 ± 0.8 | 0.8 ± 0.4 | 0.096 |
| JPD | 0.543 | ||
| Present | 13 (34)1 | 2 (67) | |
| Absent | 25 (66) | 1 (33) | |
| GB status | 1.000 | ||
| Cholecystectomy | 18 (47)1 | 1 (33) | |
| Intact GB | 20 (53) | 2 (67) | |
| With stone | 15 (39) | 2 (67) |
Three patients with mixed cholesterol and bilirubinate stones were excluded. CBD: Common bile duct; S/M: single/multiple; JPD: juxtapapillary diverticulum; GB: gallbladder.
1
Number of cases: the number inside the parenthesis shows the percentage.